GEORGE FOUNTZILAS
机构: Professor Emeritus, Aristotle University of Thessaloniki
主页: fountzilas.gr
每年引用次数
引用次数
引用: 33,185
H-指数: 83
I10-指数 : 497
出版物: 1,104
Nuclear expression of human apurinic/apyrimidinic endonuclease (HAP1/Ref-1) in head-and-neck cancer is associated with resistance to chemoradiotherapy and poor outcome.
Michael I Koukourakis , Alexandra Giatromanolaki , Stelios Kakolyris , Efthimios Sivridis
International Journal of Radiation Oncology Biology Physics 50 ( 1) 27 -36
87
2001
Primary extranodal non Hodgkin's lymphoma of the head and neck (HN-NHL)
T. Economopoulos , G. Fountzillas , A. Kostourou , J. Danlelidis
European Journal of Cancer 33
1997
The effect of temozolomide-based chemotherapy in patients with cerebral metastases from melanoma.
Dimitros Bafaloukos , Dimosthenis Tsoutsos , Georges Fountzilas , Helen Linardou
Melanoma Research 14 ( 4) 289 -294
37
2004
Non-small cell lung cancer in the young: A retrospective analysis of diagnosis, management and outcome data
G. Fountzilas , E. Efstathiou , E. Samantas , K. Syrigos
Anticancer Research 26 3175 -3181
28
2006
Adult granulosa cell tumors of the ovary: a clinicopathological study of 34 patients by the Hellenic Cooperative Oncology Group (HeCOG).
G. Fountzilas , E. Pectasides , D. Pectasides , T. Economopoulos
Anticancer Research 28 1421 -1427
19
2008
A Randomized Trial to Compare the Efficacy and Safety of Antiemetic Treatment with Ondansetron and Ondansetron Zydis in Patients with Breast Cancer Treated with High-dose Epirubicin
G. Fountzilas , U. Dafni , D.V. Skarlos , D. Pectasides
Anticancer Research 27 4411 -4417
3
2007
Epithelial ovarian cancer in Greece: a retrospective study of 1,791 patients by the Hellenic Cooperative Oncology Group (HeCOG).
G. Fountzilas , A. Bamias , D.V. Skarlos , D. Pectasides
Anticancer Research 29 ( 2) 745 -751
7
2009
Effects of Epoetin-α on Quality of Life of Cancer Patients with Solid Tumors Receiving Chemotherapy*
G. Fountzilas , U. Dafni , D. Skarlos , M. Karina
Anticancer Research 29 ( 2) 693 -702
10
2009
Combination chemotherapy with paclitaxel and gemcitabine followed by concurrent chemoradiotherapy in non-operable localized non-small cell lung cancer. A hellenic cooperative oncology group (HeCOG) phase II study.
G. Fountzilas , D. Skarlos , E. Samantas , P. Pantelakos
Anticancer Research 27 4391 -4395
4
2007
Nasopharyngeal carcinoma: Epstein-Barr Virus significance.
I. Goula , S. D. Kottaridis , E. Panotopoulou , G. Fountzilas
Anticancer Research 16 ( 2) 785 -790
4
1996
PACLITAXEL AND CARBOPLATIN AS FIRST-LINE CHEMOTHERAPY FOR ADVANCED BREAST CANCER
G. Fountzilas , C. Nicolaides , H. Kalofonos , M.-A. Dimopoulos
Oncology 12 ( 1) 45 -48
16
1998
p53 and bcl-2 expression in locally advanced squamous cell head-neck cancer treated with platinum based chemotherapy and radiotherapy.
T. Zaramboukas , V. Georgoulias , M. Koukourakis , G. Fountzilas
Anticancer Research 18 4685 -4692
12
1998
Irinotecan and vinorelbine in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy. A phase II study of the Hellenic Cooperative Oncology Group.
G. Fountzilas , D. Pectasides , H. P. Kalofonos , A. Onyenadum
Anticancer Research 22 3501 -3506
3
2002
First line combination chemotherapy with docetaxel and vinorelbine in advanced breast cancer. A phase II study.
G. Fountzilas , D. Skarlos , D. Pectasides , M. A. Dimopoulos
Anticancer Research 21 ( 5) 3575 -3580
12
2001
Paclitaxel (175 mg/m2) plus carboplatin versus paclitaxel (225 mg/m2) plus carboplatin in non-small cell lung cancer: a randomized study.
G. Fountzilas , D. Skarlos , E. Samantas , P. Kosmidis
Seminars in Oncology 24 ( 4)
18
1997
A phase II study of intraperitoneal cisplatin and etoposide in refractory or recurrent ovarian carcinoma
P. Makrantonakis , T. Giannakakis , A. Athanasiades , G. Fountzilas
Regional cancer treatment 6 ( 3) 157 -160
1993
Post-operative intracarotid chemotherapy followed by radiation therapy in patients with malignant glimas : a phase II study
G. Karkavelas , D. Sidiropoulos , C. Giavroglou , A. Vritsios
Regional cancer treatment 3 ( 6) 332 -337
2
1991
Mutations of the epidermal growth factor receptor tyrosinkinasedomain and association with slicopathological features innon-small cell lung cancer patients
G. Fountzilas , I. Kostopoulos , Jana Skřičková , P. Kosmidis
Lung Cancer
2006
Objective response to chemotherapy as a potential surrogate of survival in metastatic breast cancer patients.: Plus Commentary.
P. Bruzzi , L.D. Mastro , R. Rosso , J. Poul
Clinical Oncology 61 55 -63
2005
Randomized phase III studies of adjuvant chemotherapy with FAMTX or FEMTX in resected gastric cancer. Pooled results of studies from the EORTC GI-group and the ICCG
J. Wils , B. Baron , E. Hall , M. Lise
Proceedings of Asco
4
2002